Real‐World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL‐Chile Study

ABSTRACT Background Inotuzumab Ozogamicin (InO) has shown efficacy in relapsed/refractory acute lymphoblastic leukemia (R/R ALL), but evidence from Latin America is scarce. We evaluated the outcomes of Chilean patients treated with InO in public and private health centers. Methods We retrospectively...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Cancer Medicine
المؤلفون الرئيسيون:	Marcela Espinoza, Jorge Rojas‐Vallejos, Nicolás Rodríguez, Gonzalo Guerrero, Miguel López, Natalia Aranguiz, Guillermo Conte, Francisco Samaniego, Nicolás Quinteros, Daniel Astete, Lucas Carcamo, Constanza Flores, Ximena Huerta, Mauricio Chandía, Jorge Valenzuela, Marcelo Navarrete, Yorman Flores, Agatha Larrazabal, Edgar Zapata, Joaquín Jerez
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2025-09-01
الموضوعات:	acute lymphoblastic leukemia Inotuzumab Ozogamicin sinusoidal obstruction syndrome
الوصول للمادة أونلاين:	https://doi.org/10.1002/cam4.71230